This biotechnology expert has more than 30 years of experience in biochemistry, molecular biology, and genetics, with extensive research experience in immunology, oncology, virology, and RNA biology. His expertise includes gene expression, nucleic acids, antibodies, autoimmune and paraneoplastic disease, cancer biology, viruses, RNA-binding proteins, microRNA, RNA interference, molecular diagnostics, PCR, therapeutic proteins, biosimilars, and gene cloning. His intellectual property experience includes biotechnology patent matters involving enzymes, antibody structure and function, therapeutic antibodies, nucleic acids, human gene cloning, epigenetics, and molecular genetics. He has served as a consultant and expert witness on patent matters and has 3 years of expert witness experience. He has also participated in obtaining patents involving disease-associated antigens, DNA sequences, and related biotechnology applications.

His professional background includes service as Postdoctoral Fellow, Research Fellow, Assistant Laboratory Member, Head of a Molecular Neuro-Oncology Laboratory, Assistant Professor of Neuroscience, Associate Professor of Neuroscience, Associate Professor of Molecular, Microbial, and Structural Biology, Director of a Molecular Biology and Biochemistry Graduate Program, and President and CEO of a biotechnology company. These positions were held within medical, academic, research, and biotechnology organizations, where his work encompassed molecular biology, biochemistry, genetics, neuro-oncology, virology, oncology, monoclonal antibodies, gene-expression regulation, and biotechnology research and development. He has also reviewed federal research proposals in molecular biology, genetics, oncology, and cardiovascular research and served as a reviewer for scientific journals.

His educational background includes a Ph.D. in Biochemistry and a Bachelor of Science with Honors in Biochemistry. His scientific research has addressed paraneoplastic neurological syndromes, onco-neural antigens, tumor-associated gene regulation, angiogenesis, microRNAs, siRNA-based cancer therapeutics, and RNA-mediated regulation of human genes. He has authored numerous scientific publications and has a reported H-index of 52. His professional affiliations include the New York Academy of Sciences, The Harvey Society, and The RNA Society.